Código QR (código de barras bidimensional)

Precision medicine: Sustained response to erdafitinib in FGFR2‐mutant, multiply recurrent ameloblastoma

Abstract Background Ameloblastoma imposes significant morbidity and high‐recurrence rates following surgery and radiation therapy. Although 89% of cases harbor oncogenic mutations, the role of targeted therapy is undefined. Case We describe a case of a 40‐year‐old male with multiply recurrent, local...

Fuld beskrivelse

Na minha lista:
Principais autores: Katherine A. Lawson‐Michod, Christopher H. Le, Ghassan Tranesh, Penelope C. Thomas, Julie E. Bauman
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2022-10-01
Serier:Cancer Reports
Fag:
ameloblastoma
erdafitinib
FGFR2 mutation
precision medicine
targeted therapy
Online adgang:https://doi.org/10.1002/cnr2.1656
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker